James B. Tananbaum insider trades
Open-market stock purchases and sales by James B. Tananbaum, Unknown at Latigo Biotherapeutics, Inc, from SEC Form 4 filings since Aug 14, 2020.
Track record: 45% of 11 scored buys are up 5% or more since purchase, averaging -7%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought | $2.5M |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | ALMS Alumis Inc | Sold (not open market) | — |
| Apr 1, 2026 | ALMS Alumis Inc | Bought (not open market) | — |
| Apr 1, 2026 | ALMS Alumis Inc | Sold (not open market) | — |
| Jan 8, 2026 | ALMS Alumis Inc | Bought | $2M |
| Jan 8, 2026 | ALMS Alumis Inc | Bought | $5M |
| Nov 21, 2025 | ALMS Alumis Inc | Bought | $533K |
| Nov 19, 2025 | ALMS Alumis Inc | Bought | $1.2M |
| Nov 18, 2025 | ALMS Alumis Inc | Bought | $727K |
| Nov 17, 2025 | ALMS Alumis Inc | Bought | $839K |
| Nov 17, 2025 | ALMS Alumis Inc | Bought | $280K |
Companies traded
- LTGO Latigo Biotherapeutics, Inc: 1 buy, last Aug 10, 2026
- ALMS Alumis Inc: 11 buys, last Apr 1, 2026
- KNTE Kinnate Biopharma Inc: 5 buys, last Apr 3, 2024
- PRDS Pardes Biosciences, Inc: 1 buy, last Aug 31, 2023
- GMTX Gemini Therapeutics, Inc /DE: other filings, last Oct 4, 2021
- QSI Quantum-Si Inc: other filings, last Jun 11, 2021
- FSII FS Development Corp II: 1 buy, last Feb 19, 2021
- FSDC FS Development Corp: 1 buy, last Aug 14, 2020